I recommend minimizing alcohol, especially at the beginning of using these meds, to mitigate side effects.
"WHO recommends GLP-1 drugs for obesity." December 2025
Oxid Med Cell Longev 2018;2018:9719584 Reynaert NL, Gopal P, Rutten EPA, Wouters EFM, Schalkwijk CG
If you are weighing all your options, start with our peptide safety guide
Industry sources list prominent companies such as Bachem (Switzerland) , CordenPharma (US/Europe) , PolyPeptide Group (Sweden/US) , AmbioPharm (US) , CPC Scientific (US/China) , CSBio (US) , Creative Peptides (US) , and Lonza (Switzerland/US) ( [47] )
Supports Appetite Control with GLP-1 Activation Formulated to help you stay on track by managing hunger and promoting a feeling of fullness